CLINICAL CHARACTERISTICS OF CENTRAL EUROPEAN AND NORTH AMERICAN SAMPLES OF PREGNANT WOMEN SCREENED FOR OPIOID AGONIST TREATMENT
I tiakina i:
UNGER, A.S., ET AL., CLINICAL CHARACTERISTICS OF CENTRAL EUROPEAN AND NORTH AMERICAN SAMPLES OF PREGNANT WOMEN SCREENED FOR OPIOID AGONIST TREATMENT. EUROPEAN ADDICTION RESEARCH, Vol. 16, no. 2 (2010), p. 99-107.
Ref.
167085
Tauwāhi:
SIIS R.1142
Palabras clave:
Buprenorfina, Características usuario, Drogas ilegales, Drogodependencias, Embarazo, Metadona, Mujer, Opiáceos, Programas de mantenimiento, Reducción de daños, Tratamiento médico, Austria, Canadá, EE.UU.
Buprenorfina, Características usuario, Drogas ilegales, Drogodependencias, Embarazo, Metadona, Mujer, Opiáceos, Programas de mantenimiento, Reducción de daños, Tratamiento médico, Austria, Canadá, EE.UU.
Ngā tūemi rite: CLINICAL CHARACTERISTICS OF CENTRAL EUROPEAN AND NORTH AMERICAN SAMPLES OF PREGNANT WOMEN SCREENED FOR OPIOID AGONIST TREATMENT
- Influence of site differences between urban and rural american and central european opioid dependent pregnant women and neonatal outcome characteristics
- Interim opioid agonist treatment for opioid addiction: a systematic review
- OPIOID AGONIST PHARMACOTHERAPY IN NEW SOUTHWALES FROM 1985 TO 2006: PATIENT CHARACTERISTICS AND PATTERNS AND PREDICTORS OF TREATMENT RETENTION
- TREATMENT OF OPIOID-DEPENDENT PREGNANT WOMEN: CLINICAL AND RESEARCH ISSUES
- FROM MORPHINE CLINICS TO BUPRENORPHINE: REGULATING OPIOID AGONIST TREATMENT OF ADDICTION IN THE UNITED STATES
- Neonatal outcomes following in utero exposure to methadone or buprenorphine: A national cohort study of opioid-agonist treatment of pregnant women in Norway from 1996 to 2009